Figure 2C also shows that SkE failed to affect autophagy in K562 CML cells, as assessed by the absence of delipidation of LC3-b in cells treated with this drug. The gene discussed is MAP1LC3B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.